Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 6/20 | 0.69 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.69 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.69 |
| ▸ | GLA | P06280 | 1/20 | 0.69 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.69 |
| ▸ | MAPT | P10636 | 1/20 | 0.69 |
| ▸ | HPGD | P15428 | 1/20 | 0.69 |
| ▸ | PGAM1 | P18669 | 1/20 | 0.69 |
| ▸ | CASP1 | P29466 | 1/20 | 0.69 |
| ▸ | CASP7 | P55210 | 1/20 | 0.69 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.69 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.69 |
| ▸ | NPC1 | O15118 | 5/20 | 0.62 |
| ▸ | MEN1 | O00255 | 2/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.62 |
| ▸ | RAB9A | P51151 | 5/20 | 0.60 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.58 |
| ▸ | POLB | P06746 | 1/20 | 0.58 |
| ▸ | TTR | P02766 | 2/20 | 0.56 |
| ▸ | TBK1 | Q9UHD2 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7915081 | 0.92 | MAOA (0.54) | MAOAKDM4EALDH1A1GLACYP3A4 | |
| SCHEMBL20317255 | 0.86 | MAOA (0.60) | MAOAKDM4EALDH1A1GLACYP3A4 | |
| SCHEMBL21666688 | 0.86 | MAOA (0.78) | MAOAKDM4EALDH1A1GLACYP3A4 | |
| SCHEMBL20317251 | 0.85 | AHR (0.56) | MAOAKDM4EALDH1A1GLACYP3A4 | |
| SCHEMBL20317241 | 0.85 | MAOA (0.71) | MAOAKDM4EALDH1A1GLACYP3A4 | |
| SCHEMBL20317242 | 0.85 | NPC1 (0.55) | MAOAKDM4EALDH1A1GLACYP3A4 | |
| SCHEMBL20317277 | 0.85 | AHR (0.56) | MAOAKDM4EALDH1A1GLACYP3A4 | |
| SCHEMBL20317244 | 0.85 | MAOA (0.71) | MAOAKDM4EALDH1A1GLACYP3A4 | |
| SCHEMBL20317269 | 0.85 | MAOA (0.55) | MAOAKDM4EALDH1A1GLACYP3A4 | |
| SCHEMBL20317240 | 0.85 | NPC1 (0.55) | MAOAKDM4EALDH1A1GLACYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180179174-A1 | 12H-BENZO[b]XANTHEN-12-ONES, COMPOSITIONS CONTAINING, AND USES OF, SAME | THESAN PHARMACEUTICALS, INC. (US) | 2018-06-28 | — | — | US | disclosed |
| US-20180179174-A1 | 12H-BENZO[b]XANTHEN-12-ONES, COMPOSITIONS CONTAINING, AND USES OF, SAME | THESAN PHARMACEUTICALS, INC. (US) | 2018-06-28 | — | — | US | disclosed |
| US-20180179174-A1 | 12H-BENZO[b]XANTHEN-12-ONES, COMPOSITIONS CONTAINING, AND USES OF, SAME | THESAN PHARMACEUTICALS, INC. (US) | 2018-06-28 | — | — | US | disclosed |
| WO-2016209596-A1 | 12H-BENZO[B]XANTHEN-12-ONES, COMPOSITIONS CONTAINING, AND USES OF, SAME | THESAN PHARMACEUTICALS, INC. (US) | 2016-12-29 | — | — | WO | disclosed |
| US-8323750-B2 | Method of ultraviolet light assisted surface modification and product having a surface formed by this method | BEIJING WANHEXINYUAN BIOTECHNOLOGY CO., LTD. (CN) | 2012-12-04 | — | — | US | disclosed |
| US-8323750-B2 | Method of ultraviolet light assisted surface modification and product having a surface formed by this method | BEIJING WANHEXINYUAN BIOTECHNOLOGY CO., LTD. (CN) | 2012-12-04 | — | — | US | disclosed |
| US-20110124766-A1 | METHOD OF ULTRAVIOLET LIGHT ASSISTED SURFACE MODIFICATION AN PRODUCT HAVING A SURFACE FORMED BY THIS METHOD | BEIJING WANHEXINYUAN BIOTECHNOLOGY CO., LTD. (CN) | 2011-05-26 | — | — | US | disclosed |
| US-20110124766-A1 | METHOD OF ULTRAVIOLET LIGHT ASSISTED SURFACE MODIFICATION AN PRODUCT HAVING A SURFACE FORMED BY THIS METHOD | BEIJING WANHEXINYUAN BIOTECHNOLOGY CO., LTD. (CN) | 2011-05-26 | — | — | US | disclosed |
| US-6815481-B2 | FUSED DIBENZO THERMAL STABILIZERS SUCH AS ANTHRACENE, XANTHENE AND ANTHRONE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2004-11-09 | — | — | US | disclosed |
| US-20020032256-A1 | Polybutadiene composition | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2002-03-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180179174-A1 | 12H-BENZO[b]XANTHEN-12-ONES, COMPOSITIONS CONTAINING, AND USES OF, SAME | AHR, NR1H2, NR1H3 | MAOA 408/4885KDM4E 2074/4885ALDH1A1 1200/4885 |
| US-20110124766-A1 | METHOD OF ULTRAVIOLET LIGHT ASSISTED SURFACE MODIFICATION AN PRODUCT HAVING A SURFACE FORMED BY THIS METHOD | XPA, CYBA, PROC | MAOA 34/4885KDM4E 1160/4885ALDH1A1 2586/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.